| Literature DB >> 29077767 |
Carolyn C Ee1,2, Sharmala Thuraisingam2, Marie V Pirotta2, Simon D French3,4, Charlie C Xue5, Helena J Teede6.
Abstract
BACKGROUND: Evidence on the impact of expectancy on acupuncture treatment response is conflicting.Entities:
Mesh:
Year: 2017 PMID: 29077767 PMCID: PMC5659680 DOI: 10.1371/journal.pone.0186966
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Information about potential confounders, collected at baseline.
| Potential confounder | Categories |
|---|---|
| Never smoked, used to smoke, now smoke occasionally, or now smoke regularly | |
| Highest level of education attained (primary school, high school, college/vocational training/university degree, or postgraduate); | |
| Anxiety subscore from Hospital Anxiety and Depression Scale | |
| Real/placebo/not sure | |
| Male/female practitioner | |
| 9 point Likert scale: 1 = “not at all useful”; 9 = “very useful” |
Wording of expectancy questions in the Credibility Expectancy Questionnaire.
| Question | Range |
|---|---|
| 1 = None at all | |
| 9 = Total improvement | |
| 1 = Not at all | |
| 9 = Very much |
Participant baseline demographic characteristics.
| N = 285 | Missing | |
|---|---|---|
| Characteristic | n (%) | n (%) |
| 54.9 (4.1)* | 37 (13.0) | |
| 39 (13.7) | ||
| 237 (96.3) | ||
| 9 (3.7) | ||
| 38 (13.3) | ||
| 93 (37.7) | ||
| 154 (62.4) | ||
| 89 (31.2) | ||
| 76 (38.8) | ||
| 111 (56.6) | ||
| 9 (4.6) | ||
| 39 (13.7) | ||
| 47 (19.1) | ||
| 111 (45.1) | ||
| 73 (29.7) | ||
| 11 (4.5) | ||
| 4 (1.6) |
Fig 1Flowchart of trial procedures.
Bivariate associations between independent variables and hot flash score at EOT adjusted by baseline hot flash score (N = 285).
| Independent Variables | n | Missing n (%) | Mean change in hot flash score at EOT | |
|---|---|---|---|---|
| 6.8 (1.6) | 1 (0.4) | -0.3 (-1.1 to 0.4) | 0.42 | |
| 6.9 (1.7) | 2 (0.7) | -0.3 (-1.0 to 0.4) | 0.35 | |
| 6.8 (1.5) | - | 0.02 (-0.8 to 0.8) | 0.97 | |
| 5.1 (4.6) | 40 (14.0) | 0.1 (-0.16 to 0.38) | 0.42 | |
| 7.6 (4.2) | 35 (12.3) | -0.2 (-0.5 to 0.1) | 0.30 | |
| 9 (3.2) | 0.96 | |||
| 98 | - | |||
| 178 | 0.03 (-1.3 to 1.4) | |||
| 5 (1.8) | 0.89 | |||
| 13 | - | |||
| 91 | -1.3 (-6.7 to 4.1) | |||
| 176 | -1.0 (-6.3 to 4.3) | |||
| 37 (13.0) | 0.02 | |||
| 116 | - | |||
| 21 | -8.1 (-13.2 to -3.0) | |||
| 8 | -0.9 (-7.7 to 5.8) | |||
| 103 | -0.7 (-3.3 to 2.0) | |||
| 38 (13.3) | 0.61 | |||
| 93 | - | |||
| 109 | -1.4 (-4.3 to 1.4) | |||
| 45 | -1.00 (-4.6 to 2.6) |
*number of participants with a HF score and response for the independent variable listed. There were 37 (13%) participants with missing HF score at end of treatment.
**Mean (SD)
EOT = end of treatment